Joel Greenblatt’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Joel Greenblatt's BBIO Position: Q3 2026 in Review
Joel Greenblatt opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 6,949 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #1608 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in BBIO as recently as Q4 2023.
Joel Greenblatt first reported a position in BBIO in Q4 2023 and has held it in 2 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Joel Greenblatt held 6,949 shares of BridgeBio Pharma worth $457K as of Q3 2026.
- BridgeBio Pharma was a new Joel Greenblatt position in Q3 2026.
- BridgeBio Pharma made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1608 holding.
- Joel Greenblatt first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 2 quarters since.
- 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.